These studies indicated that ATO suppressed tumor growth and angiogenesis of HCC by regulating paracrine Ang-1 and Ang-2 secretion through the p-Akt/HIF-1α pathway after IRFA. The gene discussed is ANGPT2; the disease is hepatocellular carcinoma.